Increased natriuretic peptides in fetal hearts of diabetic rats.
The main purpose of these studies was to determine whether diabetic pregnancy altered maternal and fetal atrial natriuretic peptide (ANP). Diabetes was induced in rats by intravenous injection of 40 mg streptozotocin/kg on day 2 of gestation. Immunoreactive ANP in plasma, amniotic fluid and hearts on day 20 of gestation was measured by radioimmunoassay; fetal cardiac natriuretic peptides (ANP, proANP and BNP) were separated by reverse-phase high pressure liquid chromatography. Diabetes caused an increase in fetal plasma insulin, placental weight, amniotic fluid volume, the ratio of the fetal heart to body weight, maternal and fetal plasma ANP, fetal cardiac ANP and fetal cardiac BNP. It is suggested that the maternal diabetes-induced increase in fetal ANP might be related to fetal myocardial hypertrophy and could contribute to hydramnios.
Mulay
S
S
Department of Medicine, Royal Victoria Hospital, McGill University, Montreal, Quebec, Canada.
Conliffe
P R
PR
Varma
D R
DR
D000653:Amniotic Fluid / Q000378:metabolism; D000818:Animals; D009320:Atrial Natriuretic Factor / Q000097:blood / Q000378:metabolism*; D002851:Chromatography, High Pressure Liquid; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism*; D005260:Female; D005312:Fetal Blood / Q000378:metabolism; D005318:Fetal Heart / Q000737:chemistry / Q000378:metabolism*; D007328:Insulin / Q000097:blood; D020097:Natriuretic Peptide, Brain; D011247:Pregnancy; D011254:Pregnancy in Diabetics / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley
D007328:Insulin; D020097:Natriuretic Peptide, Brain; D009320:Atrial Natriuretic Factor